首页> 外文期刊>Nuclear Medicine and Biology >Pharmacokinetics and biodistribution of [In-111]-avidin and [Tc-99m]-biotin-liposomes injected in the pleural space for the targeting of mediastinal nodes
【24h】

Pharmacokinetics and biodistribution of [In-111]-avidin and [Tc-99m]-biotin-liposomes injected in the pleural space for the targeting of mediastinal nodes

机译:胸膜腔注射[In-111]-亲和素和[Tc-99m]-生物素-脂质体的药代动力学和生物分布,用于靶向纵隔淋巴结

获取原文
获取原文并翻译 | 示例
           

摘要

Pharmacokinetics and mediastinal node uptake of [In-111]-avidin and [Tc-99m]-biotin-liposomes following either intrapleural (pleural) or intraperitoneal (ip) injection were determined using scintigraphic imaging. Biodistribution results of [In-111]-avidin at 44 h showed 3.3% uptake in mediastinal nodes by pleural injection vs 1.3% with ip injection. Mediastinal node accumulation with [Tc-99m]-biotin-liposomes was not different between injections (0.6% ip vs 0.5% pleural). This study demonstrates the potential of the pleural route as a technique for mediastinal node targeting using the avidin/biotin-liposome system. (C) 2004 Elsevier Inc. All rights reserved.
机译:使用闪烁显像成像确定[In-111]-亲和素和[Tc-99m]-生物素-脂质体在腹膜内(胸膜)或腹膜内(ip)注射后的药代动力学和纵隔淋巴结吸收。 [In-111]-抗生物素蛋白在44 h时的生物分布结果显示,胸膜注射对纵隔淋巴结的摄取为3.3%,而腹膜内注射为1.3%。两次注射之间[Tc-99m]-生物素-脂质体的纵隔结点积聚没有差异(腹膜内0.6%vs胸膜0.5%)。这项研究证明了使用抗生物素蛋白/生物素-脂质体系统将胸膜途径作为纵隔淋巴结靶向技术的潜力。 (C)2004 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号